{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:32:22Z","timestamp":1791246742576,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,9,3]],"date-time":"2007-09-03T00:00:00Z","timestamp":1188777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,3]],"date-time":"2007-09-03T00:00:00Z","timestamp":1188777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1038\/sj.bmt.1705835","type":"journal-article","created":{"date-parts":[[2007,9,3]],"date-time":"2007-09-03T13:30:01Z","timestamp":1188826201000},"page":"935-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"40","author":[{"given":"D K L","family":"Cheuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T L","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K S","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Y","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y L","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G C F","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,3]]},"reference":[{"key":"BF1705835_CR1","first-page":"53","volume":"3","author":"L Brugieres","year":"1988","unstructured":"Brugieres L, Hartmann O, Benhamou E, Zafrani ES, Caillaud JM, Patte C et al. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. Bone Marrow Transplant 1988; 3: 53\u201358.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/01.tp.0000167758.63247.f4","volume":"80","author":"V Lapierre","year":"2005","unstructured":"Lapierre V, Mahe C, Auperin A, Stambouli F, Oubouzar N, Tramalloni D et al. Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children. Transplantation 2005; 80: 314\u2013319.","journal-title":"Transplantation"},{"key":"BF1705835_CR3","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396\u20131404.","journal-title":"Haematologica"},{"key":"BF1705835_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","volume":"32","author":"CC Barker","year":"2003","unstructured":"Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS . Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2003; 32: 79\u201387.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/00043426-200212000-00013","volume":"24","author":"U Reiss","year":"2002","unstructured":"Reiss U, Cowan M, McMillan A, Horn B . Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002; 24: 746\u2013750.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BF1705835_CR6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","volume":"22","author":"S Hasegawa","year":"1998","unstructured":"Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Bone Marrow Transplant 1998; 22: 1191\u20131197.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/pbc.20934","volume":"48","author":"SR Bulley","year":"2006","unstructured":"Bulley SR, Strahm B, Doyle J, Dupuis LL . Defibrotide for the treatment of hepatic veno-occlusive disease in children. Pediatr Blood Cancer 2006; 48: 700\u2013704.","journal-title":"Pediatr Blood Cancer"},{"key":"BF1705835_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004; 33: 189\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778\u2013783.","journal-title":"Transplantation"},{"key":"BF1705835_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BF1705835_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BF1705835_CR12","first-page":"439","volume":"10","author":"MD Blostein","year":"1992","unstructured":"Blostein MD, Paltiel OB, Thibault A, Rybka WB . A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 439\u2013443.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1097\/01.tp.0000183288.67746.44","volume":"80","author":"M Pihusch","year":"2005","unstructured":"Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Hiller E et al. Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients. Transplantation 2005; 80: 1376\u20131382.","journal-title":"Transplantation"},{"key":"BF1705835_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989; 25: 55\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1705835_CR15","first-page":"135","volume":"10","author":"V Meresse","year":"1992","unstructured":"Meresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135\u2013141.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR16","first-page":"52","volume":"26","author":"JP Gibbs","year":"1998","unstructured":"Gibbs JP, Yang JS, Slattery JT . Comparison of human liver and small intestinal glutathione S-transferase-catalyzed busulfan conjugation in vitro. Drug Metab Dispos 1998; 26: 52\u201355.","journal-title":"Drug Metab Dispos"},{"key":"BF1705835_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00277-004-0982-4","volume":"84","author":"JH Lee","year":"2005","unstructured":"Lee JH, Choi SJ, Lee JH, Kim SE, Park CJ, Chi HS et al. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan+cyclophosphamide for allogeneic bone marrow transplantation. Ann Hematol 2005; 84: 321\u2013330.","journal-title":"Ann Hematol"},{"key":"BF1705835_CR18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/01.cad.0000231482.15277.48","volume":"17","author":"J Zwaveling","year":"2006","unstructured":"Zwaveling J, den Hartigh J, Lankester AC, Guchelaar HJ, Egeler RM, Bredius RG . Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomes. Anticancer Drugs 2006; 17: 1099\u20131105.","journal-title":"Anticancer Drugs"},{"key":"BF1705835_CR19","first-page":"117","volume":"67","author":"MY Lee","year":"2004","unstructured":"Lee MY, Chiou TJ, Bai LY, Hsiao LT, Hung GY, Chang CY et al. Intravenous busulfan as preparative regimen in pediatric patients receiving hematopoietic stem cell transplantation: the preliminary experience in Taiwan. J Chin Med Assoc 2004; 67: 117\u2013122.","journal-title":"J Chin Med Assoc"},{"key":"BF1705835_CR20","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1200\/JCO.1996.14.5.1484","volume":"14","author":"JT Slattery","year":"1996","unstructured":"Slattery JT, Kalhorn TF, McDonald GB, Lambert K, Buckner CD, Bensinger WI et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. J Clin Oncol 1996; 14: 1484\u20131494.","journal-title":"J Clin Oncol"},{"key":"BF1705835_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00000421-199006000-00009","volume":"13","author":"R Brodsky","year":"1990","unstructured":"Brodsky R, Topolsky D, Crilley P, Bulova S, Brodsky I . Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan\/cyclophosphamide preparative regimen. Am J Clin Oncol 1990; 13: 221\u2013225.","journal-title":"Am J Clin Oncol"},{"key":"BF1705835_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bmt.1704784","volume":"35","author":"DW Beelen","year":"2005","unstructured":"Beelen DW, Trenschel R, Casper J, Freund M, Hilger RA, Scheulen ME et al. Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Bone Marrow Transplant 2005; 35: 233\u2013241.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR23","first-page":"225","volume":"17","author":"SP Dix","year":"1996","unstructured":"Dix SP, Wingard JR, Mullins RE, Jerkunica I, Davidson TG, Gilmore CE et al. Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant 1996; 17: 225\u2013230.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR24","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.V80.9.2425.2425","volume":"80","author":"AM Yeager","year":"1992","unstructured":"Yeager AM, Wagner Jr JE, Graham ML, Jones RJ, Santos GW, Grochow LB . Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation. Blood 1992; 80: 2425\u20132428.","journal-title":"Blood"},{"key":"BF1705835_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbmt.2005.12.028","volume":"12","author":"M Kletzel","year":"2006","unstructured":"Kletzel M, Jacobsohn D, Duerst R . Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 472\u2013479.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705835_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bbmt.2004.07.010","volume":"10","author":"H Tran","year":"2004","unstructured":"Tran H, Petropoulos D, Worth L, Mullen CA, Madden T, Andersson B et al. Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 805\u2013812.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705835_CR27","first-page":"467","volume":"7","author":"MF Ozkaynak","year":"1991","unstructured":"Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C . Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991; 7: 467\u2013474.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705835_CR28","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","volume":"104","author":"A Srivastava","year":"2004","unstructured":"Srivastava A, Poonkuzhali B, Shaji RV, George B, Mathews V, Chandy M et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood 2004; 104: 1574\u20131577.","journal-title":"Blood"},{"key":"BF1705835_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","volume":"13","author":"J Tay","year":"2007","unstructured":"Tay J, Tinmouth A, Fergusson D, Huebsch L, Allan DS . Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 206\u2013217.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705835.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705835","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705835.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:35:12Z","timestamp":1648082112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,3]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["BF1705835"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705835","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,3]]},"assertion":[{"value":"22 May 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}